Hennion & Walsh Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.22M | Buy |
|
|||||
|
2025
Q2 | $2.57M | Buy |
|
|||||
|
2025
Q1 | $2.21M | Sell |
|
|||||
|
2024
Q4 | $2.66M | Sell |
|
|||||
|
2024
Q3 | $4.34M | Buy |
|
|||||
|
2024
Q2 | $3.01M | Buy |
|
|||||
|
2024
Q1 | $2.31M | Buy |
|
|||||
|
2023
Q4 | $1.69M | Buy |
|
|||||
|
2023
Q3 | $704K | Buy |
|
|||||
|
2023
Q2 | $845K | Buy |
|
|||||
|
2023
Q1 | $720K | Buy |
|
|||||
|
2022
Q4 | $691K | Buy |
|